OBI Pharma, Inc. (TPEX:4174)
Taiwan · Delayed Price · Currency is TWD 25.15
-0.10 (-0.40%)
Jan 22, 2026, 12:50 PM CST
OBI Pharma Market Cap
OBI Pharma has a market cap or net worth of 6.64 billion as of January 21, 2026. Its market cap has decreased by -55.87% in one year.
Market Cap
6.64B
Enterprise Value
6.49B
Revenue
49.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.15
Market Cap Chart
Since December 12, 2012, OBI Pharma's market cap has decreased from 16.87B to 6.64B, a decrease of -60.63%. That is a compound annual growth rate of -6.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 6.65B | -6.30% |
| Dec 31, 2025 | 7.10B | -53.86% |
| Dec 31, 2024 | 15.39B | -3.28% |
| Dec 29, 2023 | 15.91B | 0.50% |
| Dec 30, 2022 | 15.83B | -30.20% |
| Dec 30, 2021 | 22.68B | -13.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adimmune | 8.49B |
| Acepodia | 8.38B |
| Mycenax Biotech | 7.15B |
| Savior Lifetec | 6.41B |
| Pharmosa Biopharm | 6.27B |
| CHO Pharma | 6.20B |
| Sinphar Pharmaceutical | 5.86B |
| Steminent Biotherapeutics | 5.81B |